跳至主要内容
临床试验/NCT01862276
NCT01862276已完成不适用

Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma

Kansai Hepatobiliary Oncology Group1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
3-year recurrence-free survival rate

研究概览

简要总结

To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.

详细描述

The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Cases of major hepatectomy due to intrahepatic cholangiocarcinoma

排除标准

  • 未提供

结局指标

主要结局

3-year recurrence-free survival rate

时间窗: 11 years (2000-2010)

Ratio of local recurrence at the hepatico-duodenal ligament

时间窗: 11 years

次要结局

未报告次要终点

研究者

发起方
Kansai Hepatobiliary Oncology Group
申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验